On May 18, 2023, the Supreme Court of the United States issued its decision in Amgen Inc. v. Sanofi, 22-157, ___ U.S. ___ (2023) (available here). The Court decided that patent claims directed toward ...
Article 83 of the European Patent Convention is the 'quiet clause' that can invalidate a patent for insufficient disclosure.
“Though these new guidelines may seem unnecessary, there is clear benefit to the public, especially to the applicants who rely on patents for future innovative endeavors.” The United States Patent and ...
To this end, the various types of prior art underlying long-term extrinsic patent loss in the English Patents Courts in 2000 were analyzed, distinction being made between disclosures in patent ...
December 5, 2022 - Agencies have broad discretion under their supervisory authority to request information from companies, including confidential information about secret inventions. This information ...
Author Dylan Adams is a patent attorney at the Seattle law firm Davis Wright Tremaine. He holds a master’s in electrical engineering and a bachelor’s in biochemistry. An excerpt from his recent book, ...
Dynamics of global disclosure through patent and journal publications for biopharmaceutical products
Examining the relationships between invention disclosure type in industry and academia and geographical disclosure trends, using plant-made pharmaceuticals as a single-sector model for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback